{"news_desk": "Business", "print_page": null, "subsection_name": "DealBook", "section_name": "Business Day", "byline": {"original": "By WILLIAM D. COHAN", "person": [{"firstname": "William", "rank": 1, "organization": "", "role": "reported"}]}, "abstract": null, "type_of_material": "News", "word_count": "1016", "keywords": [{"rank": "1", "value": "Suits and Litigation (Civil)", "is_major": "N", "name": "subject"}, {"rank": "2", "value": "Ackman, William A", "is_major": "N", "name": "persons"}, {"rank": "3", "value": "Allergan Inc", "is_major": "N", "name": "organizations"}, {"rank": "4", "value": "Pershing Square Capital Management", "is_major": "N", "name": "organizations"}, {"rank": "5", "value": "Valeant Pharmaceuticals International Inc", "is_major": "N", "name": "organizations"}], "lead_paragraph": "The billionaire investor William A. Ackman knew about Valeant\u2019s hostile bid for Allergan and profited from it, raising questions that could come back to haunt him.", "pub_date": "2017-02-22T23:16:40+0000", "document_type": "article", "source": "The New York Times", "snippet": "The billionaire investor William A. Ackman knew about Valeant\u2019s hostile bid for Allergan and profited from it, raising questions that could come back to haunt him....", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2017/02/23/business/23db-streetscene/23db-streetscene-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2017/02/23/business/23db-streetscene/23db-streetscene-thumbWide.jpg"}, {"height": 400, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2017/02/23/business/23db-streetscene/23db-streetscene-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2017/02/23/business/23db-streetscene/23db-streetscene-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2017/02/23/business/23db-streetscene/23db-streetscene-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2017/02/23/business/23db-streetscene/23db-streetscene-thumbStandard.jpg"}], "web_url": "http://www.nytimes.com/2017/02/22/business/dealbook/valeant-william-ackman.html", "slideshow_credits": null, "blog": [], "_id": "58ae1bdd7c459f2525d1df86", "headline": {"main": "In Valeant Stake, Still Unresolved Questions for Activist Investor", "content_kicker": "Street Scene", "kicker": "Street Scene"}}